Insider filing · BRKR

Frank H Laukien bought $5.0M of Bruker (BRKR)

Executed Nov 18 2024, disclosed Nov 19 2024, 1 day later.

Over the 21 trading sessions from the disclosed entry session (Nov 19 2024), the stock returned +13.2% (delay-adjusted); from the execution session (Nov 18 2024), +13.0%. Derived: entry at the session's open, exit at the close 20 sessions later.

FL Frank H Laukien PRESIDENT & CEO profile →

Frank H Laukien (PRESIDENT & CEO) filed 3 Form 4 reports in the past 24 months (3 purchases, 0 sales), most often in Bruker Corporation (BRKR). Across 3 priced purchase filings, the average 21-session return was +5.6% from execution and +5.1% from disclosure (delay-adjusted; derived). The largest single filing was $5.0M of BRKR (100,000 sh across 3 lots, as filed), executed Nov 18 2024.

BRKR Bruker Corporation BRKR · Healthcare · 14 filings in 24 months ticker →

Healthcare · Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diag…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→